March 17 (Reuters) - Sartorius AG SATG.DE:
EQS-NEWS: SARTORIUS SHARPENS STRATEGY WITH BIOPHARMA FOCUS AND SETS NEW MID-TERM GROWTH TARGETS
SARTORIUS AG - EXPECTS ADDRESSABLE MARKETS TO GROW 7-9% PER YEAR MEDIUM TERM
SARTORIUS AG - 2027 ONWARDS: EXPECTS COMPANY TO OUTGROW ITS ADDRESSABLE MARKETS BY AROUND 100 TO 200 BASIS POINTS PER YEAR
SARTORIUS AG - OUTLOOK FROM 2027 ONWARDS: ORGANIC SALES REVENUE GROWTH IN CONSTANT CURRENCIES OF 8 TO 11 PERCENT PER YEAR AT GROUP LEVEL.
Source text: ID:nEQ1lBvCZa
Further company coverage: SATG.DE
(Gdansk Newsroom)
(((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600);))